vs
因美纳（ILMN）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是Natera, Inc.的1.7倍（$1.2B vs $665.5M），因美纳净利率更高（28.8% vs 7.1%，领先21.7%），Natera, Inc.同比增速更快（39.8% vs 5.0%），因美纳自由现金流更多（$267.0M vs $37.8M），过去两年Natera, Inc.的营收复合增速更高（34.5% vs -0.7%）
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
ILMN vs NTRA — 直观对比
营收规模更大
ILMN
是对方的1.7倍
$665.5M
营收增速更快
NTRA
高出34.8%
5.0%
净利率更高
ILMN
高出21.7%
7.1%
自由现金流更多
ILMN
多$229.2M
$37.8M
两年增速更快
NTRA
近两年复合增速
-0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $665.5M |
| 净利润 | $334.0M | $47.3M |
| 毛利率 | 65.5% | — |
| 营业利润率 | 17.4% | -3.4% |
| 净利率 | 28.8% | 7.1% |
| 营收同比 | 5.0% | 39.8% |
| 净利润同比 | 185.5% | 187.9% |
| 每股收益（稀释后） | $2.16 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ILMNNTRA
| Q4 25 | $1.2B | $665.5M | ||
| Q3 25 | — | $592.2M | ||
| Q2 25 | — | $546.6M | ||
| Q1 25 | — | $501.8M | ||
| Q4 24 | $1.1B | $476.1M | ||
| Q3 24 | $1.1B | $439.8M | ||
| Q2 24 | $1.1B | $413.4M | ||
| Q1 24 | $1.1B | $367.7M |
净利润ILMNNTRA
| Q4 25 | $334.0M | $47.3M | ||
| Q3 25 | — | $-87.5M | ||
| Q2 25 | — | $-100.9M | ||
| Q1 25 | — | $-66.9M | ||
| Q4 24 | $186.0M | $-53.8M | ||
| Q3 24 | $705.0M | $-31.6M | ||
| Q2 24 | $-2.0B | $-37.5M | ||
| Q1 24 | $-126.0M | $-67.6M |
毛利率ILMNNTRA
| Q4 25 | 65.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 65.9% | — | ||
| Q3 24 | 69.0% | — | ||
| Q2 24 | 64.8% | — | ||
| Q1 24 | 62.0% | — |
营业利润率ILMNNTRA
| Q4 25 | 17.4% | -3.4% | ||
| Q3 25 | — | -16.5% | ||
| Q2 25 | — | -20.2% | ||
| Q1 25 | — | -15.8% | ||
| Q4 24 | 15.8% | -13.6% | ||
| Q3 24 | 68.6% | -8.9% | ||
| Q2 24 | -147.2% | -10.6% | ||
| Q1 24 | -10.3% | -20.2% |
净利率ILMNNTRA
| Q4 25 | 28.8% | 7.1% | ||
| Q3 25 | — | -14.8% | ||
| Q2 25 | — | -18.5% | ||
| Q1 25 | — | -13.3% | ||
| Q4 24 | 16.8% | -11.3% | ||
| Q3 24 | 65.3% | -7.2% | ||
| Q2 24 | -178.8% | -9.1% | ||
| Q1 24 | -11.7% | -18.4% |
每股收益（稀释后）ILMNNTRA
| Q4 25 | $2.16 | $0.36 | ||
| Q3 25 | — | $-0.64 | ||
| Q2 25 | — | $-0.74 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $1.16 | $-0.41 | ||
| Q3 24 | $4.42 | $-0.26 | ||
| Q2 24 | $-12.48 | $-0.30 | ||
| Q1 24 | $-0.79 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $1.7B |
| 总资产 | $6.6B | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ILMNNTRA
| Q4 25 | $1.6B | — | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | $93.0M | $22.7M | ||
| Q3 24 | $70.0M | $29.5M | ||
| Q2 24 | $74.0M | $90.3M | ||
| Q1 24 | — | $69.1M |
股东权益ILMNNTRA
| Q4 25 | $2.7B | $1.7B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $2.4B | $1.2B | ||
| Q3 24 | $2.1B | $878.5M | ||
| Q2 24 | $1.4B | $836.5M | ||
| Q1 24 | $5.7B | $794.1M |
总资产ILMNNTRA
| Q4 25 | $6.6B | $2.4B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $6.3B | $1.7B | ||
| Q3 24 | $6.0B | $1.6B | ||
| Q2 24 | $6.1B | $1.5B | ||
| Q1 24 | $10.0B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $321.0M | $73.9M |
| 自由现金流经营现金流 - 资本支出 | $267.0M | $37.8M |
| 自由现金流率自由现金流/营收 | 23.0% | 5.7% |
| 资本支出强度资本支出/营收 | — | 5.4% |
| 现金转化率经营现金流/净利润 | 0.96× | 1.56× |
| 过去12个月自由现金流最近4个季度 | $935.0M | $109.1M |
8季度趋势，按日历期对齐
经营现金流ILMNNTRA
| Q4 25 | $321.0M | $73.9M | ||
| Q3 25 | — | $59.4M | ||
| Q2 25 | — | $37.6M | ||
| Q1 25 | — | $44.5M | ||
| Q4 24 | $364.0M | $52.9M | ||
| Q3 24 | $316.0M | $51.8M | ||
| Q2 24 | $80.0M | $4.0M | ||
| Q1 24 | $77.0M | $27.0M |
自由现金流ILMNNTRA
| Q4 25 | $267.0M | $37.8M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | — | $11.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | $335.0M | $34.8M | ||
| Q3 24 | $284.0M | $35.5M | ||
| Q2 24 | $49.0M | $-7.7M | ||
| Q1 24 | $41.0M | $6.7M |
自由现金流率ILMNNTRA
| Q4 25 | 23.0% | 5.7% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 30.3% | 7.3% | ||
| Q3 24 | 26.3% | 8.1% | ||
| Q2 24 | 4.4% | -1.9% | ||
| Q1 24 | 3.8% | 1.8% |
资本支出强度ILMNNTRA
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | 2.6% | 3.8% | ||
| Q3 24 | 3.0% | 3.7% | ||
| Q2 24 | 2.8% | 2.8% | ||
| Q1 24 | 3.3% | 5.5% |
现金转化率ILMNNTRA
| Q4 25 | 0.96× | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ILMN
| Product revenue | $990.0M | 85% |
| Service and other revenue | $169.0M | 15% |
NTRA
暂无分部数据
